Jacob P Sizemore

Title: Jacob P Sizemore: Innovator in Pharmaceutical Chemistry

Introduction

Jacob P Sizemore is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative drug formulations and compositions. His work has implications for treating various medical conditions, showcasing his expertise and dedication to advancing healthcare solutions.

Latest Patents

Sizemore's latest patents include the development of crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide. This patent provides amorphous and crystalline hemisulfate salt forms, along with pharmaceutical compositions that utilize these forms for treating conditions associated with pyruvate kinase, such as pyruvate kinase deficiency. Another significant patent is for a crystalline form of a β-lactamase inhibitor, which details compositions containing solid forms of sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, along with methods for their manufacture and use.

Career Highlights

Throughout his career, Sizemore has worked with prominent companies in the pharmaceutical industry, including Cubist Pharmaceuticals, Incorporated and Agios Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to the development of innovative therapies and drug formulations.

Collaborations

Sizemore has collaborated with esteemed colleagues, including You Seok Hwang and Jian-Qiao Gu. These partnerships have further enriched his research and development efforts, leading to advancements in pharmaceutical science.

Conclusion

Jacob P Sizemore is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in drug formulations. His patents reflect a commitment to improving healthcare outcomes through scientific research and collaboration.